First Time Loading...
Q

Quoin Pharmaceuticals Ltd
NASDAQ:QNRX

Watchlist Manager
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Watchlist
Price: 0.7644 USD -0.09%
Updated: May 21, 2024

Quoin Pharmaceuticals Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Quoin Pharmaceuticals Ltd
Operating Income Peer Comparison

Comparables:
CGEN
B
BOLT

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Q
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Operating Income
-$9.1m
CAGR 3-Years
-35%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Compugen Ltd
NASDAQ:CGEN
Operating Income
-$13m
CAGR 3-Years
26%
CAGR 5-Years
11%
CAGR 10-Years
0%
B
Biolight Life Sciences Ltd
TASE:BOLT
Operating Income
-₪10.7m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
9%

See Also

What is Quoin Pharmaceuticals Ltd's Operating Income?
Operating Income
-9.1m USD

Based on the financial report for Mar 31, 2024, Quoin Pharmaceuticals Ltd's Operating Income amounts to -9.1m USD.

What is Quoin Pharmaceuticals Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-3%

Over the last year, the Operating Income growth was 8%. The average annual Operating Income growth rates for Quoin Pharmaceuticals Ltd have been -35% over the past three years , -3% over the past five years .